Cover Image
市場調查報告書

I型過敏症:全球臨床實驗檢討

Type I hypersensitivity Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318810
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
I型過敏症:全球臨床實驗檢討 Type I hypersensitivity Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 61 Pages
簡介

本報告提供I型過敏症的臨床試驗相關的基本資料和數據,提供您實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • I型過敏症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上I型過敏症所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

贊助商類別的臨床實驗數量

有潛力的贊助商

I型過敏症治療藥臨床實驗的主要參與企業

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Allergy Therapeutics plc
    • Merck KGaA
  • 有代表性的研究機關·醫院臨床實驗概要
    • Assistance Publique - Hopitaux de Paris

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2411CTIDB

GlobalData's clinical trial report, "Type I hypersensitivity Global Clinical Trials Review, H2, 2014" provides data on the Type I hypersensitivity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type I hypersensitivity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type I hypersensitivity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Type I Hypersensitivity
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Type I hypersensitivity to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Type I Hypersensitivity
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Type I hypersensitivity Therapeutics Clinical Trials
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Allergy Therapeutics plc
      • Clinical Trial Overview of Allergy Therapeutics plc
      • Merck KGaA
      • Clinical Trial Overview of Merck KGaA
    • Clinical Trial Overview of Top Institutes / Government
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Type I hypersensitivity Therapeutics, Global, Clinical Trials by Region, 2014*
  • Type I hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Type I hypersensitivity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Type I hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Type I hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Type I hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Type I hypersensitivity Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Type I hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Type I hypersensitivity Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Type I hypersensitivity Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Type I hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergy Therapeutics plc, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*

List of Figures

  • Type I hypersensitivity Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Type I hypersensitivity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Type I hypersensitivity to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Type I hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Type I hypersensitivity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Type I hypersensitivity Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Type I hypersensitivity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Type I hypersensitivity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Type I hypersensitivity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • GlobalData Methodology
Back to Top